home / stock / ivob / ivob quote
Last: | $ |
---|---|
Change Percent: | -1.96% |
Open: | $0.248 |
Close: | $0.2549 |
High: | $0.2549 |
Low: | $0.2351 |
Volume: | 45,161 |
Last Trade Date Time: | 02/12/2020 04:09:14 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.248 | $0.2549 | $0.2549 | $0.2351 | 45,161 | 02-12-2020 |
$ | $0.254 | $0.26 | $0.26 | $0.254 | 10,097 | 02-11-2020 |
$ | $0.2454 | $0.26 | $0.26 | $0.2454 | 102,995 | 02-10-2020 |
$ | $0.258 | $0.245 | $0.258 | $0.24 | 29,193 | 02-07-2020 |
$ | $0.25275 | $0.258 | $0.258 | $0.235 | 40,350 | 02-06-2020 |
$ | $0.26 | $0.25275 | $0.26 | $0.25275 | 46,570 | 02-05-2020 |
$ | $0.2475 | $0.26 | $0.26 | $0.2475 | 70,892 | 02-04-2020 |
$ | $0.24625 | $0.25 | $0.25 | $0.24625 | 29,810 | 02-03-2020 |
$ | $0.25375 | $0.2475 | $0.26 | $0.2475 | 45,463 | 01-31-2020 |
$ | $0.25375 | $0.25 | $0.2595 | $0.24875 | 2,100 | 01-30-2020 |
$ | $0.252 | $0.25375 | $0.2599 | $0.2475 | 20,800 | 01-29-2020 |
$ | $0.26 | $0.26 | $0.2666 | $0.2475 | 50,048 | 01-28-2020 |
$ | $0.2798 | $0.2683 | $0.2798 | $0.255 | 27,508 | 01-27-2020 |
$ | $0.25 | $0.2705 | $0.275 | $0.245 | 56,183 | 01-24-2020 |
$ | $0.24325 | $0.23 | $0.24325 | $0.2285 | 28,440 | 01-23-2020 |
$ | $0.2225 | $0.24 | $0.24 | $0.21 | 54,992 | 01-22-2020 |
$ | $0.207 | $0.22 | $0.22 | $0.207 | 16,651 | 01-21-2020 |
$ | $0.225 | $0.2214 | $0.225 | $0.2214 | 12,000 | 01-20-2020 |
$ | $0.225 | $0.2214 | $0.225 | $0.2214 | 12,000 | 01-17-2020 |
$ | $0.208 | $0.23848 | $0.23848 | $0.208 | 89,562 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
INVO BioScience, Inc. Company Name:
IVOB Stock Symbol:
OTCMKTS Market:
INVO BioScience, Inc. Website:
SARASOTA, Fla. , May 15, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today anno...
SARASOTA, Fla. , April 2, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today the appointment of Christopher A. Myer as Vice President Business Development ...
SARASOTA, Fla. , March 11, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced that Yve Lyppens has been appointed Director Business Development Asia Pacific....